Drug Action
Bacillus Calmette-Guérin is a live attenuated strain derived from Mycobacterium bovis.
PDF page 1032
Drug reference
Bacillus Calmette-Guérin is a live attenuated strain derived from Mycobacterium bovis.
PDF page 1032
Bladder instillation for the treatment of primary or recurrent bladder carcinoma and for the prevention of recurrence following transurethral resection ▶BY INTRAVESICAL INSTILLATION ▶Adult: (consult product literature)
PDF page 1032
Fever of unknown origin. HIV infection. impaired immune response. severe haematuria . tuberculosis. urinary-tract infection
PDF page 1032
Bladder injury (delay administration until mucosal damage healed). traumatic catheterisation (delay administration until mucosal damage healed). urethral injury (delay administration until mucosal damage healed)
PDF page 1032
Screen for active tuberculosis (contra-indicated if tuberculosis confirmed).
PDF page 1032
▶Common or very common Appetite decreased. arthritis. bladder cramps. bladder disorders. cardiovascular event. chills. cystitis. diarrhoea. fatigue. fever. haematuria. hepatic disorders. increased risk of infection. joint disorders. malaise. myalgia. nausea. pain. skin reactions . urinary disorders. vomiting ▶Uncommon Abdominal pain. anaemia. coagulation disorder. constipation. dizziness. genital pain. headache. leucopenia. mucositis. nephrotoxicity. stomatitis. thrombocytopenia. tissue in urine. ulcer. ureteral obstruction ▶Frequency not known Erythema nodosum. eye disorders. eye inflammation. glomerulonephritis. influenza like illness. interstitial lung disease. nephritis. renal abscess. renal failure
PDF page 1032
Avoid.
PDF page 1032
Avoid.
PDF page 1032
There can be variation in the licensing of different medicines containing the same drug. Powder for reconstitution for instillation ▶OncoTICE (Merck Sharp & Dohme Ltd) TICE strain Bacillus of Calmette-Guerin 12.5 mg OncoTICE 12.5mg powder for reconstitution for instillation vials | 1 vial P £71.61 (Hospital only)
PDF page 1032
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1032